Sign in to view content

Geographic Atrophy in the Canadian Treat and Extend Trial With Ranibizumab in nAMD Patients: CANTREAT Study 24-Month Results

Peter J. Kertes, MD, FRCS(C)

Video
Published 2019

Peter J. Kertes, MD, FRCS(C)

AMD Neovascular Part II Symposium

Related

Utility of Outer Retinal Tubulation in Predicting Lesion Growth in Subfoveal and Nonsubfoveal Geographic Atrophy
Srinivas Sai A Kondapalli, MD
Annual Meeting Talks
2023
Patients Ultra-Responsive to Ranibizumab (RBZ): Rates of Great Than or Equal to 4-Step Improvement in Diabetic Retinopathy Severity in DRCR.net Protocol S
Allen Chiang, MD, FASRS
Annual Meeting Talks
2019
The Functional Impact of Fluctuating Retinal Thickness in the IVAN and CATT Trials: A Meta-Analysis
Usha Chakravarthy
Updates from the Field
2019

Category: AMD-Neovascular

See more